FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT Lawyers Debate Off-label Regulation, Promotion [593 Words]
04/15/2015
 
 
TXT Pazdur Sees Continuing Changes in Cancer Treatment [311 Words]
04/15/2015
 
 
TXT AHIP Wants 510(k) Device Review Strengthened [391 Words]
04/16/2015
 
 
TXT FDA Reverses ‘Broadened’ Abilify Approval [347 Words]
04/13/2015
 
 
TXT FDA Seeks Public Release of Data for ALS Drug Hopeful [386 Words]
04/17/2015
 
 
TXT Be Warned: Strict Liability Cases and Jail Time on the Rise [626 Words]
04/17/2015
 
 
TXT High Court Should Decide Standing for Uninjured Plaintiffs: WLF [439 Words]
04/15/2015
 
 
TXT FDA Probes MDR Reporting of Power Morcellators: Activist [477 Words]
04/17/2015
 
 
TXT Questions Raised on Duodenoscope MDRs [752 Words]
04/16/2015
 
 
TXT FDA Approves Sandoz Generic Copy of MS Drug [309 Words]
04/16/2015
 
 
TXT DoJ Subpoena Seeks Pacira Pharma Marketing Documents [458 Words]
04/16/2015
 
 
TXT Breakthrough Designation Needs Flexibility: Tufts [398 Words]
04/15/2015
 
 
TXT FDA Denies Public Citizen ACE, ARB Petition [458 Words]
04/14/2015
 
 
TXT Since Our Last Issue ... [568 Words]
04/19/2015
 
 
TXT Latest Federal Register Notices [1406 Words]
04/19/2015
 
 
TXT Product Approval Summaries [699 Words]
04/19/2015
 
 
TXT FDA, CMS Task Force on Lab Test Oversight [401 Words]
04/16/2015
 
 
TXT FDA Workshop on Improving eHealthcare Data Collection [207 Words]
04/16/2015
 
 
TXT FDA Orders Seizure of Unapproved Drugs [231 Words]
04/16/2015
 
 
TXT Devices Must Appeal to Users: Attorney [359 Words]
04/16/2015
 
 
TXT Parenteral Drug Manufacturing Standards Petition [381 Words]
04/16/2015
 
 
TXT CDER Introduces OPQ’s ‘One Quality Voice’ [554 Words]
04/15/2015
 
 
TXT HHS Inspector General Examining Generic Drug Pricing [178 Words]
04/15/2015
 
 
TXT Latest FDA Warning Letters [349 Words]
04/14/2015
 
 
TXT Medicine Spending Up at Highest Rate Since 2001 [298 Words]
04/14/2015
 
 
TXT FDA to Court: Dismiss Risperdal Case on Petition Denial [295 Words]
04/14/2015
 
 
TXT Visionary Lens Ignores Form 483 and Gets Warning Letter [809 Words]
04/14/2015
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving
_